Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Chatelut

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Bulletin Du Cancer|April 1, 1996
[Dose optimization in clinical oncology: pharmacokinetic-pharmacodynamic relationship]P Canal, E Chatelut
Cancer Chemotherapy and Pharmacology|January 1, 1993
A slow-release methotrexate formulation for intrathecal chemotherapyE Chatelut, T Kim, S Kim
Bulletin Du Cancer|November 18, 2000
[Pharmacokinetics and individual dose adjustment of carboplatin]E Chatelut, P Canal, R Bugat
Cancer Chemotherapy and Pharmacology|January 1, 1994
An extended-release formulation of methotrexate for subcutaneous administrationA Bonetti, E Chatelut, S Kim
Journal of Pharmaceutical Sciences|March 1, 1994
Sustained-release methotrexate for intracavitary chemotherapyE Chatelut, P Suh, S Kim
Drugs|January 8, 1999
Practical treatment guide for dose individualisation in cancer chemotherapyP Canal, E Chatelut, S Guichard
Bulletin Du Cancer|November 20, 2009
[Pharmacological bases of intraperitoneal chemotherapy]L Gladieff, E Chatelut, F Dalenc, et al.
British Journal of Clinical Pharmacology|September 1, 1989
Yohimbine increases human salivary secretionE Chatelut, Y Rispail, M Berlan, et al.
Journal of Chromatography. A|September 16, 1999
Anthracycline analysis by capillary electrophoresis. Application to the analysis of daunorubicine in Kaposi sarcoma tumorN Siméon, E Chatelut, P Canal, et al.
The Journal of Antimicrobial Chemotherapy|June 9, 2017
Antiretroviral unbound concentration during pregnancy: piece of interest in the puzzle?D Metsu, P L Toutain, E Chatelut, et al.
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Bulletin Du Cancer|April 1, 1996
[Dose optimization in clinical oncology: pharmacokinetic-pharmacodynamic relationship]P Canal, E Chatelut
Cancer Chemotherapy and Pharmacology|January 1, 1993
A slow-release methotrexate formulation for intrathecal chemotherapyE Chatelut, T Kim, S Kim
Bulletin Du Cancer|November 18, 2000
[Pharmacokinetics and individual dose adjustment of carboplatin]E Chatelut, P Canal, R Bugat
Cancer Chemotherapy and Pharmacology|January 1, 1994
An extended-release formulation of methotrexate for subcutaneous administrationA Bonetti, E Chatelut, S Kim
Journal of Pharmaceutical Sciences|March 1, 1994
Sustained-release methotrexate for intracavitary chemotherapyE Chatelut, P Suh, S Kim
Drugs|January 8, 1999
Practical treatment guide for dose individualisation in cancer chemotherapyP Canal, E Chatelut, S Guichard
Bulletin Du Cancer|November 20, 2009
[Pharmacological bases of intraperitoneal chemotherapy]L Gladieff, E Chatelut, F Dalenc, et al.
British Journal of Clinical Pharmacology|September 1, 1989
Yohimbine increases human salivary secretionE Chatelut, Y Rispail, M Berlan, et al.
Journal of Chromatography. A|September 16, 1999
Anthracycline analysis by capillary electrophoresis. Application to the analysis of daunorubicine in Kaposi sarcoma tumorN Siméon, E Chatelut, P Canal, et al.
The Journal of Antimicrobial Chemotherapy|June 9, 2017
Antiretroviral unbound concentration during pregnancy: piece of interest in the puzzle?D Metsu, P L Toutain, E Chatelut, et al.
Pageof 8